Alcon, CH0432492467

Systane Complete by Alcon Inc. - dry eye relief built on oil-based drops

Published on 07/24/2026 at 12:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Systane Complete targets all layers of the tear film with an oil-enhanced formula for dry eyes. This product is driving the price of Alcon Inc. stock (ISIN CH0432492467).

Black and white photojournalism style. Ophthalmologist using slit-lamp biomicroscope to examine patient seated in optometry chair, strong chiaroscuro contrast, documentary grain, intimate clinical moment captured in wide horizontal frame
Alcon CH0432492467: Schwarz Weiß Fotografie eines Augenarztes mit Spaltlampe und Patient im Untersuchungsstuhl, Illustration mit AI erstellt.

Systane Complete lands on the bathroom shelf with a small white-and-purple bottle that feels cool in the hand, the milky drop spreading across the eye in seconds instead of running straight down the cheek. The product is built by Alcon around an oil-enhanced formula for dry eyes. In Zürich, Alcon chief executive David J. Endicott likes to highlight how this lubricant line anchors the company’s consumer eye care portfolio.

What Systane Complete actually is

Systane Complete is a preservative-free lubricant eye drop designed for people with dry eye symptoms, from burning and scratchy feelings to blurred vision at the end of the day. The emulsion is formulated to support all three layers of the tear film, using tiny oil droplets to stabilize the outer lipid layer and slow evaporation.

The bottle uses a modern multi-dose system that keeps the solution sterile without adding traditional preservatives, a key point for frequent users who worry about long-term exposure. The drop itself looks slightly cloudy compared with classic clear saline, a visible sign of the lipid component that Alcon and its formulators talk about in technical papers.

Dig deeper & contextualize

Alcon eye care revenues and dry eye portfolio

How lubricant drops like Systane Complete sit alongside surgical and contact lens businesses in Alcon Inc.’s financials.

How the formulation works day to day

Alcon positions Systane Complete for people with both aqueous-deficient and evaporative dry eye, meaning those whose eyes either do not produce enough tears or lose moisture too quickly. A company explainer describes how the mineral oil and phospholipid components help rebuild the lipid layer, while polymer ingredients support the watery and mucin layers.

Users are typically instructed to shake the bottle before each use to evenly disperse the lipid droplets, then apply one or two drops into the affected eye as needed. On the eye, the solution is designed to spread smoothly across the cornea, providing a sensation of relief that some patients liken to a gentle cooling film rather than a thin splash of water.

Who Systane Complete is aimed at

The target group includes office workers who stare at screens, older adults with age-related dry eye and contact lens wearers seeking relief between wearing periods. Alcon says Systane Complete is suitable for people with mild to moderate dry eye disease and can be used up to several times per day, though the product information usually recommends consulting an eye care professional for persistent symptoms.

Product managers at Alcon have repeatedly framed Systane as an umbrella brand covering different formulations, from classic Systane Ultra to Systane Hydration and Systane Complete. In investor presentations, David J. Endicott has pointed out that this breadth helps Alcon address different patient profiles and price points in over-the-counter eye care.

Pricing, packaging and availability

In major European markets, Systane Complete is sold over the counter in pharmacies and online, typically in 10 ml multi-dose bottles with a recommended retail price around 15 to 20 euros depending on channel and local taxes. The packaging emphasizes "complete" tear film support and preservative-free dosing, using a white background with purple and teal accents and a graphic of an eye surrounded by a droplet.

In the United States, Alcon offers Systane Complete in similar preservative-free bottles, with prices in the range of 15 to 25 dollars at large retailers according to recent listings. The company promotes the product through ophthalmology conferences and professional education materials, where clinicians like Dr. Derek Cunningham have discussed using lipid-enhanced lubricants for patients with meibomian gland dysfunction, a frequent cause of evaporative dry eye.

Regulatory status and safety profile

Regulatory filings show that Systane Complete is registered as an over-the-counter medical device or drug product depending on jurisdiction, focusing on temporary relief of symptoms rather than disease modification. Labeling typically warns users not to touch the dropper tip to any surface, to avoid contamination, and to discard the bottle after its recommended use period once opened.

Alcon’s materials highlight that the preservative-free multi-dose system reduces exposure to benzalkonium chloride, a classic preservative associated with surface toxicity in long-term use. That point resonates with dry eye specialists, who often prefer preservative-free options for patients needing more than four applications per day, especially those with existing ocular surface damage.

Role inside Alcon’s business and the stock

Within Alcon, consumer eye care, including lubricant eye drops like Systane Complete, sits alongside surgical devices and vision care such as contact lenses and solutions. While revenue from lubricants is smaller than surgical platforms, it provides recurring sales and direct brand exposure to millions of consumers, which investors watch as a stabilizing element in the business mix.

On the Swiss exchange SIX, Alcon Inc. stock trades in Swiss francs, and analysts routinely link the performance of its consumer segment to broader discussions about margins and portfolio resilience. For holders of Alcon Inc. stock, Systane Complete and the wider Systane line form a relevant contributor to recurring eye care revenue.

Key facts about Systane Complete

  • Product: Systane Complete
  • Manufacturer: Alcon Inc.
  • Category: Lifestyle / consumer eye drops
  • Market launch: Around 2018, depending on region
  • MSRP / Price: Approximately 15-20 EUR for 10 ml in European markets
  • Availability: Over-the-counter in pharmacies and online in Europe and North America
  • Target group: Adults with mild to moderate dry eye, including screen users and older patients
  • Highlight / USP: Preservative-free multi-dose lipid-enhanced formula targeting all layers of the tear film

Search Systane Complete on social media

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0432492467 | ALCON | boerse | 69861669 |